Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Alexander Rosén

Alexander Rosén

individual
Capital ownerEcosystem influencer

About

Alexander Rosén is a Swedish co-founder and Chief Administrative Officer of Jupiter Neurosciences, a Nasdaq-listed clinical-stage biotech developing therapies for neuroinflammation, Alzheimer's disease, and rare neurological disorders. Company materials say he has been with Jupiter since inception and previously worked in administration and controller roles at X-VAX Technology. SEC filings also show he holds a meaningful insider equity stake in Jupiter Neurosciences.

Areas of interest

biotechneuroscienceneuroinflammationAlzheimer's diseaserare diseasesdrug developmentlongevity